Optimi Health Corp. Common Shares (OPTH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Optimi Health Corp. Common Shares (OPTH) has a cash flow conversion efficiency ratio of -0.162x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.01 Million) by net assets ($12.42 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Optimi Health Corp. Common Shares for the company's overall valuation and market capitalisation.
Optimi Health Corp. Common Shares - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Optimi Health Corp. Common Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Optimi Health Corp. Common Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Optimi Health Corp. Common Shares ranked by their cash flow conversion efficiency. See OPTH operating cash flow to total debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
eMnet Inc
KQ:123570
|
-0.022x |
|
SIAV S.P.A.
F:F4U
|
N/A |
|
Korean Drug Co. Ltd
KQ:014570
|
0.024x |
|
Xali Gold Corp
V:XGC
|
0.115x |
|
BIONXT SOLUTIONS INC.
F:BXT
|
0.080x |
|
Hunyvers SA
PA:ALHUN
|
0.032x |
|
Aetherium Acquisition Corp
NASDAQ:GMFI
|
N/A |
|
Lotus Eye Hospital and Institute Limited
NSE:LOTUSEYE
|
0.008x |
Annual Cash Flow Conversion Efficiency for Optimi Health Corp. Common Shares (2020–2025)
The table below shows the annual cash flow conversion efficiency of Optimi Health Corp. Common Shares from 2020 to 2025. View OPTH stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $6.58 Million | $-2.63 Million | -0.399x | +10.68% |
| 2024-09-30 | $9.58 Million | $-4.28 Million | -0.447x | -64.02% |
| 2023-09-30 | $13.21 Million | $-3.60 Million | -0.273x | +4.63% |
| 2022-09-30 | $16.02 Million | $-4.58 Million | -0.286x | +0.01% |
| 2021-09-30 | $21.07 Million | $-6.02 Million | -0.286x | -953.85% |
| 2020-09-30 | $5.29 Million | $-143.45K | -0.027x | -- |
About Optimi Health Corp. Common Shares
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more